Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease

Journal of Hypertension

Volumn 22, Issue 11, 2004, Pages 2201-2208

  Galderisi, Maurizio ^a,b   Cicala, Silvana ^a   D'Errico, Arcangelo ^a   De Divitiis, Oreste ^a   De Simone, Giovanni ^a  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Arterial hypertension; Coronary flow reserve; Doppler echocardiography; Nebivolol

Indexed keywords

DIPYRIDAMOLE; NEBIVOLOL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERTENSION; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 7744238322     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200411000-00024     Document Type: Article

References (45)

1. Polese A, De Cesare N, Montorsi P, Fabbiocchi F, Guazzi M, Loaldi A, et al. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation 1991; 83:845-853.
2. Brush JE, Canon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319:1302-1307.
3. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88:993-1003.
4. Vogt M, Motz W, Strauer BE. Coronary hemodynamics in hypertensive heart disease. Eur Heart J 1992; 13(suppl D):44-49.
5. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87:86-93.
6. Strauer BE, Schwartzlopff B, Kelm M. Assessing the coronary circulation in hypertension. J Hypertens 1998; 16:1221-1233.
7. Kozàkovà M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Mechanisms of coronary flow reserve impairment in human hypertension. Hypertension 1997; 29:551-559.
8. Kozakova M, Galetta F, Gregorini L, Bigalli C, Franzoni F, Giusti C, et al. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy. Hypertension 2000; 36:343-349.
9. Palombo C, Kozakova M, Magagna A, Bigalli C, Morizzo C, Ghiadoni P, et al. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens 2000; 18:453-459.
10. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozakova M, La Canna G, et al. Relationships between coronary flow vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens 2003; 21:625-631.
11. Kozakova M, de Simone G, Morizzo C, Palombo C. Coronary vasodilator capacity and hypertension-induced increase in left ventricular mass. Hypertension 2003; 41:224-229.
12. Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 2000; 35:1654-1660.
13. Galderisi M, Cicala S, Caso P, De Simone L, D'Errico A, Petrocelli A, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial systemic hypertension. Am J Cardiol 2002; 90:860-864.
14. Galderisi M, Caso P, Cicala S, De Simone L, Barbieri M, Vitale G, et al. Positive association between circulating free IGF-1 and coronary flow reserve in arterial systemic hypertension. Am J Hypertens 2002; 15:766-772.
15. Galderisi M, de Simone G, Cicala S, Caso P, De Simone L, D'Errico, et al. Coronary flow reserve in hypertensive patients with appropriate and inappropriate left ventricular mass. J Hypertens 2003; 21:1-6.
16. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 196; 27:1031-1038.
17. Schwartzkopff B, Brehm M, Mundhenke M, Strauer B. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000; 36:220-225.
18. Van de Water A, Janssens W, Van Nuten J, Xhonneux R, De Cree J, Verhaegen H, et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta-1-adrenergic antagonist. Cardiovasc Pharmacol 1988; 11:552-563.
19. Van Neuten L, Taylor FR, Robertson JL. Nebivolol versus atenolol and placebo in essential hypertension: a double-blind randomized trial. J Hum Hypertens 1998; 12:135-140.
20. Ignarro LJ, Byrns RE, Trinh K, Sisodia M, Buga GM. Nebivolol: a selective beta(1)adrenergic receptor antagonist relaxes vascular smooth muscle by nitric oxide- and cyclic GMP dependent mechanisms. Nitric Oxide 2002; 7:75-82.
21. Cockcroft JR, Chowiencyk PJ, Brett SE, Mant TG, Dumin C, Dynn F, et al. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO dependent mechanism. J Pharmacol Exp Ther 1995; 274:1067-1071.
22. Dawes M, Brett SE, Chowiencyk PJ, Mant TG, Ritter JM. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension. Br J Clin Pharmacol 1999; 48:460-463.
23. de Simone G, Scalfi L, Galderisi M, Celentano A, Di Biase G, Tammaro P, et al. Cardiac abnormalities in young women with anorexia nervosa. Br Heart J 1994; 71:287-292.
24. de Simone G, Mureddu GF, Greco R, Scalfi L, Del Puente AE, Franzese A, et al. Relations of left ventricular geometry and function to body composition in children with high casual blood pressure. Hypertension 1997; 30:377-382.
25. Galderisi M, Paolisso G, Tagliamonte MR, Alfieri A, Petrocelli A, de Divitiis M, et al. Is insulin action a determinant of left ventricular relaxation in uncomplicated essential hypertension? J Hypertens 1997; 15:745-750.
26. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25:1056-1062.
27. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, et al. Assessment of left ventricular function by the midwall function shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451.
28. Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein AS. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989; 79:872-883.
29. Dubin J, Wallerson DC, Cody RJ, Devereux RB. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J 1990; 120:116-123.
30. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. A new non-invasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999; 99:771-778.
31. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986; 1:307-310.
32. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995; 91:1624-1628.
33. Froelich ED. Risk mechanisms in hypertensive heart disease. Hypertension 1999; 34:782-789.
34. Hoffman JH. A critical view of coronary reserve. Circulation 1987; 75(suppl I):6-11.
35. Rossen JD, Winniford MD. Effects of increase in heart rate and arterial pressure on coronary flow reserve in humans. J Am Coll Cardiol 1003; 21:343-348.
36. Sudhir K, MacGregor JS, Barbant SD, Foster E, Fitzgerald PJ, Chatterjee K, et al. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound. J Am Coll Cardiol 1993; 21:1261-1268.
37. Kuo L, Davis MJ, Chilian WH. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 1990; 259:H1063-H1070.
38. Drexler H, Zeiber AM, Wollschlager H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilation in humans. Circulation 1989; 80:466-474.
39. 1-selective receptor blockade. J Hypertens 2002; 20:421-428.
40. Kalinowski L, Dobrucki LW, Szcepanska-Konkel M, Jankowski M, Martyniec L, Angieski S, et al. Third-generation β-blockers stimulate nitric oxide release from endothelial cells through ATP efflux. A novel mechanism for antihypertensive action. Circulation 2003; 107:2742-2752.
41. Altman JD, Kinn J, Duncker DJ, Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in dogs. Cardiovasc Res 1994; 1:119-124.
42. Wilson RF, Laughin DE, Ackell PH, Chilian WM, Holida MD, Hartley CJ, et al. Transluminal subselective measurement of coronary blood flow velocity and vasodilator reserve in man. Circulation 1985; 72:82-92
43. Picano E, Lattanzi F, Masini M, L'Abbate A. High dose dipyridamole echocardiography test effort in angina pectoris. J Am Coll Cardiol 1986; 8:848-854.
44. Lim HE, Shim WJ, Rhee H, Kim SM, Hwang GS, Kim JH, et al. Assessment of coronary flow reserve with transthoracic Doppler echocardiography: comparison among adenosine, standard-dose dipyridamole and high-dose dipyridamole. J Am Soc Echocardiogr 2000; 13:264-270.
45. Kamp O, Sieswerda GT, Visser CA. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. Am J Cardiol 2003; 92:344-348.